| Phase 4 |
| NCT06690164 |
Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone |
Metabolite |
Recruiting |
2025-07-02 |
| NCT07031128 |
Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS) |
CABG |
Recruiting |
2025-06-22 |
| NCT07329582 |
Hyperbaric Bupivacaine Versus Hyperbaric Prilocaine in Spinal Anaesthesia |
Knee Replacement, Total |
Active, Not Recruiting |
2026-01-09 |
| NCT06943482 |
Comparing Effectiveness of Steroids and Methotrexate in Treatment of Chronic Inflammatory… |
Idiopathic Granulomatous Mastitis |
Not Yet Recruiting |
2025-04-24 |
| Phase 3 |
| NCT05473520 |
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue… |
Tuberculosis |
Recruiting |
2026-06-09 |
| Phase 2/3 |
| NCT06530459 |
The MUSE Study for Menopausal Arthralgia |
Arthralgia |
Recruiting |
2024-07-31 |
| NCT07241715 |
Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE) |
Gastric Cancer Stage IV |
Active, Not Recruiting |
2026-05-14 |
| Phase 2 |
| NCT06446245 |
Adjunctive Doxycycline for Central Nervous System Tuberculosis |
Tuberculosis, Meningeal |
Recruiting |
2026-06-01 |
| NCT07091175 |
Dupilumab Therapy in Nephrotic Syndrome in Children |
Nephrotic Syndrome in Children |
Recruiting |
2025-12-05 |
| NCT05305131 |
Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin… |
Nasopharyngeal Cancer |
Recruiting |
2025-09-23 |
| NCT05181033 |
Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post… |
Breast Cancer |
Recruiting |
2025-07-25 |
| NCT05719428 |
Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid… |
Solid Organ Malignancies |
Recruiting |
2025-07-25 |
| NCT06846268 |
Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer |
Locally Advanced Colorectal Cancer |
Recruiting |
2025-07-25 |
| NCT06923826 |
Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) |
Salivary Gland Cancer |
Recruiting |
2025-07-25 |
| NCT06062823 |
Study of EGFR TKI in Patients With Advanced NSCLC Harbouring EGFR Mutations |
NSCLC |
Recruiting |
2025-07-24 |
| NCT06422403 |
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced… |
Carcinoma, Hepatocellular |
Recruiting |
2025-01-10 |
| NCT06733948 |
ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients |
Nasopharyngeal Carcinoma |
Recruiting |
2024-12-13 |
| NCT06336395 |
Ma-Spore ALL 2020 Study |
B Lymphoblastic Leukemia |
Recruiting |
2024-03-28 |
| NCT06782048 |
Use of Pyrvinium to Reverse Stomach Precancerous Conditions |
STOMACH NEOPLASM |
Not Yet Recruiting |
2026-10-13 |
| NCT07565389 |
Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma |
Nasopharyngeal Carcinoma (NPC) |
Not Yet Recruiting |
2026-05-04 |
| Phase 1/2 |
| NCT07319676 |
Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas |
B-cell Lymphoma Refractory |
Recruiting |
2026-04-09 |
| NCT05381038 |
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours… |
Solid Tumor |
Recruiting |
2025-09-23 |
| NCT05035745 |
Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple… |
Advanced Refractory Solid Tumors |
Recruiting |
2025-07-25 |
| NCT05491083 |
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer |
Advanced Solid Tumor |
Recruiting |
2025-07-25 |
| NCT07681297 |
Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors… |
Advanced Solid Tumor Cancer |
Not Yet Recruiting |
2026-07-10 |